<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04581655</url>
  </required_header>
  <id_info>
    <org_study_id>ONCOTIPNET</org_study_id>
    <nct_id>NCT04581655</nct_id>
  </id_info>
  <brief_title>ONCOTIPNET: Multicenter Study on Risk Factors and Outcome in Cancer Pediatric Patients Admitted in Italian PICUs</brief_title>
  <acronym>ONCOTIPNET</acronym>
  <official_title>Retrospective and Prospective Analysis of Risk and Outcome Factors in Oncohematological Patients Admitted to Italian Pediatric Intensive Care Units: a Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera di Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliera di Padova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will describe characteristics of pediatric cancer patients admitted to Italian&#xD;
      PICUs and will analyze risk factors of PICU admission, neurological outcome, and mortality.&#xD;
      After a retrospective analysis (2019-2020), investigators will perform a prospective study&#xD;
      over 12 months gathering data from 15-20 Italian PICUs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aim to evaluate:&#xD;
&#xD;
        1. characteristics of pediatric cancer patients admitted to Italian PICUs&#xD;
&#xD;
        2. risk factors of PICU admission, neurological outcome and mortality.&#xD;
&#xD;
      Inclusion criteria: age &lt;= 18 years, informed consent. Exclusion criteria: informed consent&#xD;
      not obtained. After a retrospective analysis (2019-2020), investigators will perform a&#xD;
      prospective study over 12 months (March 2021 - February 2021) gathering data from 15-20&#xD;
      Italian PICUs. Each Center can decide whether to participate only in the prospective phase.&#xD;
      Data will be recorded in an electronic data collection form in Red Cap.&#xD;
&#xD;
      The following variables will be collected:&#xD;
&#xD;
        -  Demographic variables: age, sex, ethnicity;&#xD;
&#xD;
        -  TIP pre-admission clinical variables and at the time of admission: basic diagnosis,&#xD;
           comorbidity, Hemopoietic Stem Cell Transplantation (TCSE) number and type, treatment&#xD;
           phase, HLA matching, Graft Versus Host (GVH) and grade, veno-occlusive disease, Venous&#xD;
           Occlusive Disease&#xD;
&#xD;
        -  Variables upon entering TIP: PIM3, POPC score, organ failure cause and staging, high&#xD;
           intensity treatments, high flow oxygen therapy, dialysis, inotropes or other, fluid&#xD;
           overload, immunodeficiency&#xD;
&#xD;
        -  Clinical variables during hospitalization: organ failure cause and staging, ventilation,&#xD;
           modality, presence of pARDS and severity, need for inotropic support, sepsis and&#xD;
           severity score (SOFA), inotropes (VIS score), arrest event cardiac, need for HFOV,&#xD;
           Extra-Corporeal Membrane Oxygenator, Nitric Oxide, dialysis, Intracranial Pressure&#xD;
           monitoring, drugs used for sedation, development of withdrawal syndrome, development of&#xD;
           delirium.&#xD;
&#xD;
      Considering the participation of 15-20 centers involving 20 patients in a year, the expected&#xD;
      number is 600 patients considering the retrospective phase (optional, therefore some Centers&#xD;
      may not contribute) and the prospective phase.&#xD;
&#xD;
      Study sites will also take part to a survey designed to collect data in order to describe&#xD;
      Italian PICUs involved in providing care to cancer patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>from date of patient's admission in PICU to date of PICU discharge assessed up to 7 days</time_frame>
    <description>rate of dead patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>from discharge to 30th day after PICU discharge</time_frame>
    <description>30-days mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>from 31st to 90th day after PICU discharge</time_frame>
    <description>90-days mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neurological outcome</measure>
    <time_frame>on date of PICU discharge assessed up to 10 days</time_frame>
    <description>patients's Pediatric Overall Performance Category (POPC) score (a 6 level score: 4 to 6 is considered bad outcome)</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pediatric Cancer</condition>
  <condition>Critically Ill</condition>
  <eligibility>
    <study_pop>
      <textblock>
        pediatric patients with cancer disease admitted in PICU&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &lt;= 18 yeras&#xD;
&#xD;
          -  informed consent*&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  informed consent not obtained*&#xD;
&#xD;
               -  only for next prospective part of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>angela amigoni, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Padova</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>angela amigoni, Dr</last_name>
    <phone>339 8333765</phone>
    <phone_ext>39</phone_ext>
    <email>angela.amigoni@aopd.veneto.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>marta pillon, Dr</last_name>
    <email>marta.pillon@unipd.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Salesi Hospital</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandro Simonini</last_name>
    </contact>
    <investigator>
      <last_name>Alessandro Simonini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Giovanni XIII Hospital</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ezio Bonanomi</last_name>
    </contact>
    <investigator>
      <last_name>Ezio Bonanomi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Policlinico S.Orsola-IRCCS</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabio Caramelli</last_name>
    </contact>
    <investigator>
      <last_name>Fabio Caramelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spedali Civili Hospital, University of Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatrice Vasile</last_name>
    </contact>
    <investigator>
      <last_name>Beatrice Vasile</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>I Policlinico</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marinella Astuto</last_name>
    </contact>
    <investigator>
      <last_name>Marinella Astuto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meyer Hospital</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manuela L'Erario</last_name>
    </contact>
    <investigator>
      <last_name>Manuela L'Erario</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gaslini Hospital</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Moscatelli</last_name>
    </contact>
    <investigator>
      <last_name>Andrea Moscatelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Messina</name>
      <address>
        <city>Messina</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eloisa Gitto</last_name>
    </contact>
    <investigator>
      <last_name>Eloisa Gitto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital V. Buzzi-Sacco</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefania Ferrario</last_name>
    </contact>
    <investigator>
      <last_name>Stefania Ferrario</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santobono Hospital</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Geremia Zito Marinosci</last_name>
    </contact>
    <investigator>
      <last_name>Geremia Zito Marinosci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedale Università Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Amigoni, Dr</last_name>
      <phone>339 8333765</phone>
      <phone_ext>39</phone_ext>
      <email>angela.amigoni@aopd.veneto.it</email>
    </contact>
    <contact_backup>
      <last_name>Marta Pillon, Dr</last_name>
      <email>marta.pillon@unipd.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Di Cristina Hospital</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Alaimo</last_name>
    </contact>
    <investigator>
      <last_name>Nicola Alaimo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>&quot;Bambino Gesù&quot; Children's Hospital</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabriella Bottari</last_name>
    </contact>
    <investigator>
      <last_name>Gabriella Bottari</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emanuele Rossetti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regina Margherita Hospital</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giorgia Maiolo</last_name>
    </contact>
    <investigator>
      <last_name>Giorgia Maiolo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Burlo Garofalo Hospital</name>
      <address>
        <city>Trieste</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raffaella Sagredini</last_name>
    </contact>
    <investigator>
      <last_name>Raffaella Sagredini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Verona</name>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Biban</last_name>
    </contact>
    <investigator>
      <last_name>Paolo Biban</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.Bortolo Hospital</name>
      <address>
        <city>Vicenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Zanonato</last_name>
    </contact>
    <investigator>
      <last_name>Elisa Zanonato</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Pillon M, Amigoni A, Contin A, Cattelan M, Carraro E, Campagnano E, Tumino M, Calore E, Marzollo A, Mainardi C, Boaro MP, Nizzero M, Pettenazzo A, Basso G, Messina C. Risk Factors and Outcomes Related to Pediatric Intensive Care Unit Admission after Hematopoietic Stem Cell Transplantation: A Single-Center Experience. Biol Blood Marrow Transplant. 2017 Aug;23(8):1335-1341. doi: 10.1016/j.bbmt.2017.04.016. Epub 2017 Apr 28.</citation>
    <PMID>28461212</PMID>
  </results_reference>
  <results_reference>
    <citation>Pillon M, Sperotto F, Zattarin E, Cattelan M, Carraro E, Contin AE, Massano D, Pece F, Putti MC, Messina C, Pettenazzo A, Amigoni A. Predictors of mortality after admission to pediatric intensive care unit in oncohematologic patients without history of hematopoietic stem cell transplantation: A single-center experience. Pediatr Blood Cancer. 2019 Oct;66(10):e27892. doi: 10.1002/pbc.27892. Epub 2019 Jun 28.</citation>
    <PMID>31250548</PMID>
  </results_reference>
  <results_reference>
    <citation>Wösten-van Asperen RM, van Gestel JPJ, van Grotel M, Tschiedel E, Dohna-Schwake C, Valla FV, Willems J, Angaard Nielsen JS, Krause MF, Potratz J, van den Heuvel-Eibrink MM, Brierley J; POKER (PICU Oncology Kids in Europe Research group) research consortium. PICU mortality of children with cancer admitted to pediatric intensive care unit a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019 Oct;142:153-163. doi: 10.1016/j.critrevonc.2019.07.014. Epub 2019 Aug 3.</citation>
    <PMID>31404827</PMID>
  </results_reference>
  <results_reference>
    <citation>Faraci M, Bagnasco F, Giardino S, Conte M, Micalizzi C, Castagnola E, Lampugnani E, Moscatelli A, Franceschi A, Carcillo JA, Haupt R. Intensive care unit admission in children with malignant or nonmalignant disease: incidence, outcome, and prognostic factors: a single-center experience. J Pediatr Hematol Oncol. 2014 Oct;36(7):e403-9. doi: 10.1097/MPH.0000000000000048.</citation>
    <PMID>24276033</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 21, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera di Padova</investigator_affiliation>
    <investigator_full_name>angela amigoni</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pediatric intensive care unit</keyword>
  <keyword>oncology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We will share individual participant data set with participating centers. Moreover we will share: Study Protocol, Statistical Analysis Plan (SAP), Informed Consent Form (ICF), Clinical Study Report (CSR)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

